Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Flexion Therapeutics

    Client Virtual Booth

    FLEXION THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Flexion Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    10 Mall Road, Suite 301, Burlington, MA 01803
    Telephone
    Telephone
    781.305.7777
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://flexiontherapeutics.com
    Linkedin
    Linkedin
    https://in.linkedin.com/company/flexion-therapeutics
    Twitter
    Twitter
    https://twitter.com/FlexionInc?ref

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    After buying out Flexion for $450M, Pacira quietly lays off 110 of its employees
    After buying out Flexion for $450M, Pacira quietly lays off 110 of its employees

    https://endpts.com/after-buying-out-flexion-for-450m-pacira-quietly-laid-off-110-of-its-employees/

    P. Schloesser ENDPTS
    04 Mar 2022
    Share Share
    Pacira buys Flexion for $450M to boost pain offerings
    Pacira buys Flexion for $450M to boost pain offerings

    https://www.fiercepharma.com/pharma/pacira-boosts-non-opioid-pain-portfolio-via-450m-flexion-buy-more-cvr-payments-to-come

    Angus Liu FIERCEPHARMA
    12 Oct 2021
    Share Share
    Supernus and Pacira swoop while their targets are down
    Supernus and Pacira swoop while their targets are down

    https://www.evaluate.com/vantage/articles/news/deals/supernus-and-pacira-swoop-while-their-targets-are-down

    Madeleine Armstrong EVALUATE
    11 Oct 2021
    Share Share
    Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635
    Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635

    https://www.globenewswire.com/news-release/2021/10/01/2307364/29848/en/Flexion-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    01 Oct 2021
    Share Share
    Flexion Announces Inclusion of ZILRETTA in AAOS Clinical Practice Guidelines
    Flexion Announces Inclusion of ZILRETTA in AAOS Clinical Practice Guidelines

    https://www.globenewswire.com/news-release/2021/09/02/2290770/29848/en/Flexion-Therapeutics-Announces-Inclusion-of-ZILRETTA-in-American-Academy-of-Orthopaedic-Surgeons-AAOS-Clinical-Practice-Guidelines-for-the-Management-of-Osteoarthritis-of-the-Knee.html

    GLOBENEWSWIRE
    02 Sep 2021
    Share Share
    Flexion expands P1b Trial in FX301 for the Management of Post-Operative Pain
    Flexion expands P1b Trial in FX301 for the Management of Post-Operative Pain

    https://www.globenewswire.com/news-release/2021/08/25/2286225/29848/en/Flexion-Therapeutics-Announces-Expansion-of-Phase-1b-Trial-Investigating-FX301-for-the-Management-of-Post-Operative-Pain.html

    GLOBENEWSWIRE
    25 Aug 2021
    Share Share
    Flexion Therapeutics Reports Second-Quarter 2021 Financial Results
    Flexion Therapeutics Reports Second-Quarter 2021 Financial Results

    https://www.globenewswire.com/news-release/2021/08/04/2274951/29848/en/Flexion-Therapeutics-Reports-Second-Quarter-2021-Financial-Results-and-Recent-Business-Highlights.html

    GLOBENEWSWIRE
    04 Aug 2021
    Share Share
    Flexion Therapeutics to Second-Quarter 2021 Financial Results on August 4, 2021
    Flexion Therapeutics to Second-Quarter 2021 Financial Results on August 4, 2021

    https://www.globenewswire.com/news-release/2021/07/29/2271780/29848/en/Flexion-Therapeutics-to-Report-Second-Quarter-2021-Financial-Results-on-August-4-2021.html

    GLOBENEWSWIRE
    29 Jul 2021
    Share Share
    Flexion Announces Appointment of Utpal Koppikar to its Board of Directors
    Flexion Announces Appointment of Utpal Koppikar to its Board of Directors

    https://www.globenewswire.com/news-release/2021/07/12/2261512/29848/en/Flexion-Therapeutics-Announces-Appointment-of-Utpal-Koppikar-to-its-Board-of-Directors.html

    GLOBENEWSWIRE
    12 Jul 2021
    Share Share
    Flexion Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Flexion Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com/news-release/2021/07/02/2257341/29848/en/Flexion-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    02 Jul 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search